ZORZON, MARINO
 Distribuzione geografica
Continente #
NA - Nord America 7.394
AS - Asia 3.859
EU - Europa 3.041
SA - Sud America 545
AF - Africa 64
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 14.917
Nazione #
US - Stati Uniti d'America 7.331
SG - Singapore 1.479
CN - Cina 897
UA - Ucraina 790
IT - Italia 554
BR - Brasile 438
HK - Hong Kong 392
VN - Vietnam 312
SE - Svezia 305
KR - Corea 287
FI - Finlandia 275
FR - Francia 252
TR - Turchia 229
GB - Regno Unito 191
PL - Polonia 126
RU - Federazione Russa 119
IE - Irlanda 117
BG - Bulgaria 115
DE - Germania 89
BD - Bangladesh 63
IN - India 60
AR - Argentina 30
NL - Olanda 29
IQ - Iraq 28
CA - Canada 24
BE - Belgio 21
AT - Austria 20
MX - Messico 19
JP - Giappone 18
ZA - Sudafrica 18
MA - Marocco 17
ID - Indonesia 16
PY - Paraguay 15
EC - Ecuador 14
CO - Colombia 13
PK - Pakistan 13
IR - Iran 10
JO - Giordania 10
CL - Cile 9
VE - Venezuela 9
AU - Australia 8
CH - Svizzera 8
PE - Perù 8
EG - Egitto 7
ES - Italia 7
PH - Filippine 7
AL - Albania 5
KZ - Kazakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
BO - Bolivia 4
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
SN - Senegal 4
UY - Uruguay 4
CR - Costa Rica 3
DK - Danimarca 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
RO - Romania 1
SR - Suriname 1
TH - Thailandia 1
UG - Uganda 1
ZM - Zambia 1
Totale 14.917
Città #
Singapore 850
Fairfield 748
Jacksonville 676
Woodbridge 640
Ashburn 616
Wilmington 417
Houston 411
Ann Arbor 401
Hong Kong 388
San Jose 386
Chandler 341
Seattle 298
Hefei 294
Seoul 285
Cambridge 272
Princeton 228
Izmir 214
Beijing 202
Boardman 151
Chicago 147
Santa Clara 124
Dublin 115
Sofia 115
Zgierz 113
Columbus 109
Buffalo 98
Milan 97
Ho Chi Minh City 96
Lauterbourg 96
Dallas 84
Hanoi 81
Los Angeles 79
Moscow 79
The Dalles 69
San Diego 51
Verona 48
Helsinki 45
New York 36
Dearborn 34
São Paulo 34
Bremen 23
Norwalk 23
Trieste 22
Washington 22
Brussels 21
Frankfurt am Main 21
Venezia 16
Da Nang 15
Brooklyn 14
Düsseldorf 14
Mumbai 14
Nuremberg 14
Rome 14
Tokyo 14
London 13
Rio de Janeiro 13
Denver 11
Haiphong 11
Johannesburg 11
Phoenix 11
Warsaw 11
Auburn Hills 10
Chennai 10
Guangzhou 10
Toronto 10
Casablanca 9
Munich 9
Nanjing 9
Tianjin 9
Amman 8
Brasília 8
Kunming 8
Amsterdam 7
Baghdad 7
Belo Horizonte 7
Can Tho 7
Dhaka 7
Quito 7
Redondo Beach 7
Shanghai 7
Vienna 7
Barnet 6
Boston 6
Caracas 6
Hangzhou 6
Hải Dương 6
Jinan 6
Miano 6
Salvador 6
San Mateo 6
Zhengzhou 6
Augusta 5
Bexley 5
Biên Hòa 5
Bogotá 5
Carosino 5
Dalian 5
Leawood 5
New Delhi 5
Porto Alegre 5
Totale 10.164
Nome #
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis. 301
Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue. 253
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls. 242
Bilingual aphasia and subcortical-cortical lesions. 234
Ultrasound findings of the optic nerve and its arterial venous system in multiple sclerosis patients with and without optic neuritis vs. healthy controls. 223
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 208
Acute encephalopathy and polyneuropathy after disulfiram intoxication. 197
MMP-9 microsatellite polymorphism and multiple sclerosis. 195
Acute akinesia, an unusual complication in Parkinson’s disease: a case report 191
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. 190
Mielite recidivante:esordio clinico di neuromielite ottica? 184
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 182
Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature. 180
A longitudinal study of quality of life and side effects in patients with Multiple Sclerosis treated with Interferon beta-1a. 180
CORRELATION OF SEXUAL DYSFUNCTION AND BRAIN MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS 180
HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. 179
Depressive symptoms and MRI changes in multiple sclerosis 174
HLA GENOTYPES AND DISEASE SEVERITY ASSESSED BY MAGNETIC RESONANCE IMAGING FINDINGS IN PATIENTS WITH MULTIPLE SCLEROSIS. 174
A longitudinal study of brain atrophy and cognitive disturbances in early phase of relapsing-remitting multiple sclerosis 171
Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival. 169
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. 167
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. 167
Outcome of medication overuse headache after abrupt in-patient withdrawal. 166
Trigeminal neuralgia due to contralateral meningioma of the posterior cranial fossa. 162
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. 160
Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 157
Effect of intravenous methylprednisolone in the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 157
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 156
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. 155
Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. 155
Headache induced by Chronic substance use:analysis of medication overused and minimum dose required to induce headache. 154
Proton magnetic resonance spectroscopy during transient global amnesia 153
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study 152
Efficacia del mesoglicano nella terapia della placca ateromasica dei vasi epiaortici 150
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. A CASE-CONTROL STUDY. I. FREQUENCY AND COMPARISON OF GROUPS 149
Case Report: Coexistence of SUNCT and Hypnic Headache in the Same Patient 146
Nontraumatic headache in the Emergency Department: a survey in the province of Trieste. 144
OLFACTORY LOSS IN MULTIPLE SCLEROSIS 144
Aritmie cardiache ed ischemia cerebrale acuta. Studio con monitoraggio Holter 144
Clinical surveillance of patients with multiple sclerosis 140
Central nervous system atrophy in Multiple Sclerosis: Introduction. 138
Familial and environmental risk factors in Parkinson's disease: a case control study in North-East Italy. 138
Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis. 138
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS 137
Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. 137
MRI TECHNIQUES AND COGNITIVE IMPAIRMENT IN EARLY PHASE OF RELAPSING-REMITTING MULTIPLE SCLEROSIS 135
Risk factors of multiple sclerosis:a case-control study. 135
Atrial fibrillation and acute ischemic cerebrovascular disease. Study of 500 cases of cerebral infarction and transient cerebral ischemic attacks 135
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. 134
Sclerosi multipla in overlap con sindrome di Sjogren 134
Incidence and prevalence of motor neuron disease in Coastal and Mountanious Regions, Croatia, 1984-1993. A preliminary survey. 133
Beta 2-microglobulin level is not a marker of disease activity in Multiple Sclerosis. 132
Prevalence of migraine in Croatia: a population-based survey. 131
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjectsJ 129
Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. 129
Epstein-Barr Virus is Associated with Gray Matter Atrophy in Multiple Sclerosis 129
Sexual dysfunction in multiple sclerosis. A MRI, neurophysiological and urodynamic study 128
Concordance of carotid bruit and positivity of computerized digital angiography of the epiaortic vessels in carotid stenotico-occlusive pathology 128
Approccio multidisciplinare alla Sclerosi Multipla. SPSM-RIabilitazione 128
Hyperglycemia at ischemic stroke onset as prognostic factor. 127
Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. 126
Cysts of the atlantoaxial joint: excellent long-term outcome after posterolateral surgical decompression. Report of two cases. 123
Aspetti epidemiologici e clinici dello stroke. 121
Hypnic headache:rapid and long-lasting response to prednisone in two new cases. 120
Persistent aura without infarction:description of the first case studied with both brain SPECT and perfusion MRI. 120
Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis 120
Trattamento con cicli di megadosi di metilprednisolone in pazienti affetti da sclerosi multipla cronico-progressiva: valutazione clinica a tre anni 120
Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. 118
Donna e Sclerosi Multipla. I disturbi della sfera sessuale nelle pazienti con sclerosi multipla. 113
Terapia antiossidante nell’ictus ischemico acuto 112
Update sul Teriflunomide 112
Magnetic resonance imaging techniques as predictors of cognitive impairment in multiple sclerosis 111
Proton magnetic resonance spectroscopy study of ischemia in intracerebral hemorrhage 111
THE USE OF STANDARDIZED INCIDENCE AND PREVALENCE RATES IN EPIDEMIOLOGICAL STUDIES ON MULTIPLE SCLEROSIS. A META-ANALYSIS STUDY 110
Il management del paziente di nuova diagnosi. La comunicazione della diagnosi. 107
L'aderenza alla terapia nella sclerosi multipla. Il punto di vista del medico 107
Use of ticlopidine in patients with acute non-embolic cerebral infarcts 106
Diagnosi e gestione del paziente con sclerosi multipla. Il paziente CIS 105
Side-effects and changes in systemic arterial pressure after administration of a single dose of lorazepam 104
Discordanza tra attività di malattia clinica e in risonanza magnetica 103
Relationship between central nervous system atrophy and genetic-immunological markers in Multiple Sclerosis 101
Disabilità e Qualità della Vita nelle persone colpite da Sclerosi Multipla 101
Increased density in the middle cerebral artery by nonenhanced computed tomography. Prognostic value in acute cerebral infarction. 100
La rieducazione equestre: una possibilità riabilitativa 99
Focus on:ECTRIMS e SIN 2006 99
Gaucher’s disease with Parkinson’s disease: Clinical and pathological aspects 98
The blood level of uric acid as a risk factor in transient cerebral ischemic attacks and in non-embolic acute cerebral infarct 96
Fumo di sigaretta e rischio d'insorgenza delle vasculopatie cerebrali acute di tipo ischemico 96
Fattori prognostici nell'emorragia cerebrale primitiva sopratentoriale 95
SFAAT: Studio della fibrillazione atriale cronica non reumatica nell’area triestina. Risultati dell’arruolamento 94
Frontal parenchimal atrophy measures in multiple sclerosis. 93
Le crisi ischemiche cerebrali transitorie e prolungate (TIA e RIND) 93
Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis. A clinical and MRI study 92
Familial nature of acute cerebral vasculopathies of the ischemic type 90
Ematocrito, emoglobina, numero di globuli rossi e bianchi in rapporto al rischio di insorgenza delle vasculopatie cerebrali acute di tipo ischemico 90
Hematocrit and hemoglobin in the pathogenesis of transient cerebral ischemic attacks 88
The latero-cervical murmur. Clinical and etiological observations on 515 cases belonging to a group of 2782 subjects examined 88
Il morbo di Parkinson 88
Hematocrit value and hemoglobin concentration as possible risk factors in non-embolic acute cerebral infarcts 87
Ticlopidine and pentoxifylline in acute cerebral infarct. Clinical study on 151 patients 87
Totale 13.884
Categoria #
all - tutte 47.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022852 28 95 12 92 4 32 31 58 143 106 100 151
2022/20231.175 136 68 130 142 117 255 29 89 153 3 43 10
2023/2024761 27 29 35 57 132 44 45 236 6 33 77 40
2024/20251.799 10 95 74 170 270 211 70 96 245 115 138 305
2025/20264.338 275 399 598 489 324 384 479 161 391 606 144 88
2026/20274 4 0 0 0 0 0 0 0 0 0 0 0
Totale 14.960